TP53 and colorectal carcinoma: To determine whether the tissue of origin impacts GOT1 dependence, we compared GOT1 knockdown in a panel of PDA and CRC cell lines that similarly exhibit mutant KRAS (or BRAF) and mutant TP53 expression (Fig. 1b).